NCT01286467 - A Study Of PF-04449913 Administered Alone In Select Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 11, 2011

Primary Completion Date

May 10, 2012

Study Completion Date

December 28, 2012

Conditions

Solid Tumors

Interventions

DRUG

PF-04449913

Escalating dose of PF-04449913 administered as tablets PO QD in 28-day cycles

Trial Locations (9)

Anschutz Cancer Pavilion, Aurora

University of Colorado Denver, Aurora

University of Colorado Hospital, Aurora

Keck Hospital of University of Southern California, Los Angeles

Los Angeles County-University of Southern California Medical Center, Los Angeles

University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service, Los Angeles

University of Southern California/Norris Comprehensive Cancer Center, Los Angeles

Brigham and Women's Hospital (BWH), Boston

Dana-Farber Cancer Institute (DFCI), Boston